6505--Radiopharmaceuticals - Vizamyl and Datscan
ID: 36C24525Q0350Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF245-NETWORK CONTRACT OFFICE 5 (36C245)LINTHICUM, MD, 21090, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/4f57657ec9c9429b9d3ae1c88e4d0c8d/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking sources for the procurement of two radiopharmaceuticals, Vizamyl and Datscan, through a Sources Sought Notice. This procurement aims to gather information on potential suppliers' capabilities for delivering these products to the Nuclear Medicine Section at the DC Veterans Affairs Medical Center, with an initial contract period of 12 months and four renewal options. The radiopharmaceuticals are critical for providing necessary medical services to veterans, ensuring accurate diagnosis and treatment. Interested contractors must submit their responses by March 7, 2025, at 12 PM Eastern Time, and can contact Contracting Officer Ryan Singletary at ryan.singletary@va.gov or 202-745-8000 for further details.

    Point(s) of Contact
    RYAN SINGLETARYCONTRACTING OFFICER
    (202) 745-8000
    RYAN.SINGLETARY@VA.GOV
    Files
    Title
    Posted
    36C24525Q0350_1.docx
    The Department of Veterans Affairs (VA) is seeking sources for the procurement of two radiopharmaceuticals, Vizamyl and Datscan, through a Sources Sought Notice. This notice is not a solicitation but aims to gather information for planning purposes regarding the capabilities of potential suppliers. The contract will cover an initial 12-month period with four renewal options, focusing on the delivery of these radiopharmaceuticals to the Nuclear Medicine Section at the DC Veterans Affairs Medical Center. Interested contractors must provide their company's information, including size status, manufacturing capabilities, and pricing for the products. The contract requires deliveries to occur Monday through Friday, the use of an online ordering system, compliance with safety regulations, and couriers must be licensed. Additionally, the contractor must ensure all doses are calibrated correctly and that staff receives necessary training regarding the products. Responses to the request must be submitted by March 7, 2025, at 12 PM Eastern Time to the provided contact. The document outlines the requirements for participation, emphasizing that this notice does not commit the government to any purchases. This procurement effort reflects the VA's commitment to providing necessary medical services to veterans through specialized pharmaceutical supplies.
    Lifecycle
    Title
    Type
    6505--Radiopharmaceuticals - Vizamyl and Datscan
    Currently viewing
    Sources Sought
    Similar Opportunities
    6505--Lab supplies - Radiopharm - Amyvid
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for a five-year indefinite delivery indefinite quantity (IDIQ) contract to supply Amyvid injectables for Positron Emission Tomography (PET) imaging at the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, Pennsylvania. The contract will require an estimated thirty-six doses of Amyvid per year, which are critical for diagnosing Alzheimer's disease in veterans. Proposals are due by 3:00 PM EST on March 6, 2025, with questions accepted until March 4, 2025, and the total contract value is capped at $1,000,000. Interested vendors must comply with federal regulations and safety guidelines, and they can contact Contracting Officer Victoria Droz at Victoria.Droz@va.gov or 814-515-4454 for further information.
    6525--Nuclear Medicine NEURACEQ F-18 FLORBETABEN PET DEP
    Buyer not available
    The Department of Veterans Affairs is seeking small business vendors to provide F-18 Florbetaben PET doses for the Lexington VA Medical Center, as outlined in the combined synopsis and solicitation (RFQ 36C24925Q0157). The procurement involves a five-year contract for the delivery of specified quantities of radiopharmaceuticals, with orders required to be placed 24 hours prior to patient studies and delivered 15-30 minutes before calibration time. This initiative is crucial for ensuring timely access to essential medical imaging supplies, thereby enhancing the quality of healthcare services provided to veterans. Interested vendors must submit their quotes by March 6, 2025, and can direct inquiries to Contract Specialist Ayslin Kennett at Ayslin.Kennett@va.gov.
    6505--Radiopharmaceuticals For The Portland VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceuticals for the Portland VA Medical Center. This opportunity, identified by solicitation number 36C26025Q0237, aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply essential nuclear medicine supplies, ensuring 24/7 availability and prompt delivery for patient care. The procurement is particularly significant as it supports the medical needs of veterans while promoting participation from Service-Disabled Veteran-Owned Small Businesses (SDVOSB). Interested vendors must submit their proposals by March 28, 2025, at 13:00 Pacific Time, and can direct inquiries to José Ronstadt at jose.ronstadt@va.gov or by phone at 360-852-9885.
    6505--Radiopharmaceutical Isotopes (Cardiology)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceutical isotopes specifically for cardiology applications at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. The contract aims to secure isotopes such as 99mTc-Tetrofosmin and 131I-Sodium Iodide, which are essential for diagnostic testing and quality assurance in nuclear cardiology procedures, with a contract period extending from April 1, 2025, to March 31, 2030, and options for renewal. This opportunity is critical for suppliers in the medical sector to support the VA's healthcare delivery, emphasizing compliance with federal regulations and quality control standards. Interested small businesses must submit their proposals by March 6, 2025, at 5:00 PM Eastern Time, and can direct inquiries to Contracting Officer Stacy Massey at Stacy.Massey@va.gov or by phone at 414-844-8400.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the provision of radiopharmaceuticals to the Naval Medical Center Portsmouth, with a contract period extending from April 1, 2025, to March 31, 2030. The procurement encompasses a range of medical isotopes and imaging agents, including Tc-99m Medronate, I-123 NaI, and F-18 FDG, which are critical for various diagnostic and therapeutic applications in cancer treatment and medical imaging. This initiative underscores the government's commitment to ensuring the availability of essential medical resources to support public health initiatives, with a focus on compliance with safety regulations and quality standards. Interested vendors must submit their proposals by March 11, 2025, and direct any inquiries to Carol Uebelacker at carol.e.uebelacker.civ@health.mil or by phone at 210-952-8111.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire high-tech medical imaging equipment, specifically targeting the needs of the National Acquisition Center (NAC) for various healthcare facilities serving veterans. The procurement process is crucial for enhancing healthcare services, ensuring that the VA can provide state-of-the-art diagnostic and treatment capabilities. Key deadlines include the submission of vendor questions by February 19, 2025, and the final offer submission due by April 9, 2025. Interested vendors should direct inquiries to Contract Specialist Hermann A. Degbegni at hermann.degbegni@va.gov for further details.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6525--Nuclear Medicine Trailer Lease
    Buyer not available
    The Department of Veterans Affairs is seeking vendors for a one-year lease of a Mobile Nuclear Medicine Trailer for the Fayetteville VA Medical Center. The procurement requires mobile nuclear medicine systems, such as the Siemens E.cam or Philips Forte, along with equivalent models approved by the VA, equipped with essential features like a built-in hot lab, patient wheelchair lift, injection room, waste disposal units, and a backup generator. This service is crucial for providing uninterrupted patient care, with operational hours set from Monday to Friday, 7:30 AM to 4:00 PM. Interested vendors must submit their company details and capabilities statement to Contracting Specialist Patsy Simpson via email by March 6, 2024, and must be registered in the System for Award Management (SAM) to participate.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    Q999--TeleRadiology Services Philadelphia VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking qualified contractors to provide teleradiology services for the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, PA. This initiative aims to address physician shortages in diagnostic imaging by ensuring timely interpretations of radiological examinations, particularly during off-hours and emergencies, with a focus on maintaining high standards of care and compliance with privacy regulations. The contract will require remote image interpretation services by U.S.-based, board-certified radiologists, with performance metrics including rapid reporting times for STAT and routine examinations. Interested parties, particularly Service-Disabled Veteran-Owned Small Businesses (SDVOSB) and Veteran-Owned Small Businesses (VOSB), must submit a statement of interest and capability statement to Contract Specialist Jami Cade at Jami.Cade@va.gov by March 5, 2025, as part of this Sources Sought Notice. The contract duration is anticipated to be four years, contingent on funding and performance adherence.